Clin2
NCT03914391Possibly a fitRecruiting

Find new urine tests to screen for prostate cancer

Prostate Cancer

Part of Cancer, Kidney & urinary clinical trials.

This study looks for new urine markers (signals) that could help screen for prostate cancer. If you have a higher PSA blood test and are scheduled for a prostate biopsy, your urine sample may be studied to see if it can improve screening.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are an adult man (older than 18 years)
  • Your PSA blood test result is higher than 4 ng/mL
  • You are planning to have a prostate biopsy soon
  • No urinary tract infection in the last 6 weeks
  • No urine/urethra procedures (like a catheter or cystoscopy) in the last 6 weeks
  • You can give consent and are willing to provide a urine sample

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03893929Recruiting
Test new markers to help diagnose prostate cancer

This study looks for new biological markers in men to improve how prostate cancer is diagnosed and followed. If you have signs that might be prostate cancer, your tests may help researchers find better clues for future care.

Shatin
NCT03237026Recruiting
Urine tests to predict outcomes in prostate cancer treatment

This study looks for urine markers (proteins and metabolites) that may help predict how prostate cancer patients respond to treatment and what their outcomes are. You may be asked to give a urine sample and allow use of your medical and treatment details for analysis (results are not shared with you).

Taipei
NCT07468838Not yet recruiting
Urine test for monitoring prostate or bladder cancer

This trial is testing if a simple urine test can help track prostate or bladder cancer over time without needing invasive procedures. It includes five specific patient groups with different stages of these cancers.

NCT03784924Recruiting
Prostate MRI study to find blood and urine cancer signals

This study enrolls men who may have prostate cancer but do not yet have a diagnosis. It uses prostate MRI along with blood and urine tests to see if specific signals can help identify prostate cancer sooner.

Ann Arbor, Michigan
NCT07454603Recruiting
Blood test for prostate cancer risk

This trial tests a new blood test to help decide if you need a prostate biopsy. It may help men with high PSA levels or an abnormal rectal exam avoid unnecessary procedures.

Branford, Connecticut
NCT06966089Not yet recruiting
Testing a urine test for men with high PSA and normal MRI

This study tests a new urine test (ExosomeDx) to see if it can help find prostate cancer in men who have a high PSA but a normal MRI. It aims to avoid unnecessary biopsies by using a more accurate screening method.

New York, New York

Hear when a new Prostate cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.